BioSpace News Archive

Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”) today announced it will report financial results for the third quarter ended September 30, 2022 and highlights of recent progress on Thursday, November 10, 2022.

Solid Biosciences Inc., a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy, announced that it will implement a 1-for-15 reverse split of its common stock.

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market opens on Thursday, November 3 rd . IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

PDS Biotechnology Corporation, a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, provided highlights from its Head and Neck Cancer Key Opinion Leader Roundtable.

Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that the Company is amending the date for its reverse stock split, due to an unanticipated delay in obtaining necessary regulatory clearances.

Ardelyx, Inc. today announced that it will hold a conference call on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time to review third quarter 2022 financial results and provide a business overview.

Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the third quarter and first nine months of 2022 after market close on November 10, 2022.

Triumvira Immunologics today announced that it will present data from its ongoing clinical and preclinical programs at the upcoming Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, being held Nov. 10-12, 2022.

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock.